Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • RCL vs MRNA✓SelectedUSD · MRNARCL vs MRNA performance historyLatest closeAs of-1.69%11/16
Stock and ETF performance explorer

RCL vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+226.5%
MRNA return
+878.5%
Excess return
-652.0%
Maximum drawdown
-83.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-1.7%-3.6%+1.9%-1.6%
7D-5.7%-20.0%+14.3%-4.9%
30D+14.5%-1.3%+15.7%+14.4%
3M+4.8%+240.0%-235.1%-2.2%
6M+23.5%+339.0%-315.5%+13.0%
YTD+15.8%+630.0%-614.1%+2.6%
1Y+28.2%+769.1%-740.9%+12.5%
3Y+217.1%+181.2%+35.8%+186.6%
5Y+294.5%-8.1%+302.6%+250.7%
All+226.5%+878.5%-652.0%+220.9%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling